Table 3.
Author | Response Criteria |
Response Rate1 (%) |
1-yr Survival (%) |
Median Survival (months) |
---|---|---|---|---|
Fiorentini | NR | 50 | NR | NR |
Muchmore | WHO* | 46 | NR | NR |
Link | WHO | 19 | NR | 12 (Stage III) 4 (Stage IV) |
Lorenz | WHO | 0 | NR | 4.2 |
Maurer | WHO | 8 | NR | 6 |
Klapdor | WHO | 46 | NR | 9 |
Homma | WHO | 58 | 67 | NR |
Bayar | WHO* | 36 | NR | 8 |
Ohigashi | WHO* | 6 | 56 | 13 |
van Ijken | WHO | 5^ | NR | 6 |
Aigner | NR | NR | NR | 9 |
Takamori | WHO | 21 | 51 | 14 |
Barletta | WHO* | 22 | 50 | 6.1 |
Mambrini | SWOG | 8 | NR | 9.2 |
Meyer | NR | 18 | 6 | 4.1 |
Guadagni | WHO* | 18 | 9 | 6 |
Ikeda | WHO* | 24 | NR | 13 |
Ishikawa | WHO | 25 | 45 | 12 |
Milandri | WHO | 25^ | 16 | 6 |
Nakchbandi | NR | NR | 6 | 6.8 |
Sasada | RECIST | 58^ | 83 | 22 |
Response rate reflects partial and complete responses; mixed or minor responses not included
WHO criteria as described in methods, however WHO criteria reference not cited.
response rate based on fraction of total number of patients treated
WHO, World Health Organization; SWOG, Southwest Ongology Group; RECIST, Response Evaluation Criteria In Solid Tumors.